Ehlers-Danlos Australia

Ehlers-Danlos Australia An Australian awareness page for Ehlers-Danlos Syndrome and its associated conditions. A hub for sharing articles, facts and related support groups.

03/09/2026

1) Many patients with orthostatic intolerance do not meet the require heart rate increase of POTS criteria.

This new expert consensus paper argues that that this group deserves more recognition, including a separate diagnosis and ICD-code.

2) In the paper they call this group "Non-POTS dysautonomia" but explain that this is just a preliminary description. I personally do not like this term because it still referring to POTS and the term dysautonomia is problematic in itself.

3) Dys-autonomia suggests there is a known, measurable defect in the autonomous nervous system - something we don't fully know yet. POTS was originally coined for patients with orthostatic intolerance but few signs of clear autonomic dysfunction.

4) IMHO the core problem is what to do with patients who have orthostatic intolerance symptoms and disability without a known cause and without clear signs of dysautonomia. The distinction between those with and without orthostatic tachycardia (POTS or not) may be less important

5) You can see this in the consensus statement which argue that both groups may have similar impairments, symptoms and that the same treatments may be useful for both. Orthostatic tachycardia is a useful clinical feature but perhaps not sufficient to base a syndrome on.

6) The panel of 40 experts formulated several other consensus statements, including for example, that "POTS and other autonomic disorders are not functional neurologic disorders" and that POTS is not caused by fear of standing or avoidance behavior.

7) The 40 experts were not anonymous and there was only one round of voting because of high consensus on most statements. For ME/CFS, experts included Stephanie Grach, Kathryn Hoffmann, Peter Rowe and Michael Stingl.

8) Link to the paper:

Sivakoti et al. 2026. Postural Orthostatic Tachycardia Syndrome (POTS) and Dysautonomia: International Multidisciplinary Expert Consensus.
https://pubmed.ncbi.nlm.nih.gov/42665152/

02/09/2026

Medical notes showed hospital staff witnessing Trinity Hutchins vomiting blood, but specialists were still suspicious.

22/08/2026
19/08/2026

Piper Makin was diagnosed with the autonomic nervous system condition POTS after a period of deteriorating health.

Her mother, Kylie Makin, started a page to search for information and community connections around the condition.

They want to raise awareness about the condition to improve the chances of others finding a diagnosis and treatment.

Read Sam Bradbrook and Becc Bird's story here: https://www.abc.net.au/news/2026-08-19/pots-women-diagnosis-rural-regional-patients-healthcare-sa/107016870

18/08/2026
Be interesting to read and check out.
16/08/2026

Be interesting to read and check out.

A review published in the International Journal of Molecular Sciences discussed a study of 400 people with mastocytosis, a condition involving abnormal accumulation of mast cells. Among them, 15 also had autism (3.75%). Using the general-population autism prevalence cited at the time (about 1 in 180), the authors described this as approximately 6.75 times higher. Importantly, this was an observed association and does not show that mast-cell activation causes autism.

Researchers have proposed several possible biological connections between mast cells, inflammation, and ASD. Activated mast cells can release histamine, cytokines, tryptase and other inflammatory substances that may affect the blood-brain barrier and interact with microglia, the brain's resident immune cells. The review discusses the possibility that these processes contribute to neuroinflammation in a subset of people with ASD. However, the authors conclude that the relationship between mast cells and autism remains controversial and poorly understood, and more research is needed to determine whether mast-cell abnormalities influence ASD development or symptoms.

More work behind getting this new phenotype recognised.
13/08/2026

More work behind getting this new phenotype recognised.

“Once recognized, never overlooked.”

It’s the philosophy at The Center for Neuro-EDS and Craniospinal Disorders (home of world-renowned neurosurgeon, Dr. Paolo Bolognese). It’s a breakthrough acknowledgment that patients with connective tissue disorders often belong to a subgroup that suffers from complex neurological conditions, like , , , , , , , , , and more.

It is with gratitude that we congratulate Dr. Allison R. Bloom, Dr. Ilene S. Ruhoy, Dr. Randall A. Dass, Dr. Amanda Lerner, Dr. Paolo B. Bolognese, and Dr. Petra M. Klinge on the preprint release of their groundbreaking position paper, “Defining Neuro-EDS: A Neuro-Predominant Phenotype in hEDS/HSD and Related Heritable Connective Tissue Disorders.”

Thousands of patients have received life-changing and life-saving interventions as these pioneers in medicine have learned (from the patients themselves) that connective tissue biology often gives rise to a collection of neurological, cranial, spinal, autonomic, neurovascular, and immune-inflammatory manifestations.

An estimated 10-30%+ of hypermobile patients may belong to a neuro-EDS phenotype. At last, there is a vocabulary and a growing consensus around how to recognize this suffering and offer validation, diagnostic clarity, and treatment. We encourage you to learn from this important article, to share it widely, and to become part of the conversation. If you see yourself in this article, we encourage you to show it to members of your medical team so they can, at last, see you too.

It is our ardent hope that this conversation and this work is just the beginning — that neuro-EDS patients, once recognized, will never again be overlooked.

POSTQUAM VISIBILE, NUMQUAM NEGLECTUM

https://www.preprints.org/manuscript/202608.0567

𝐈𝐭’𝐬 𝐧𝐨𝐭 𝐚𝐥𝐥 𝐢𝐧 𝐨𝐮𝐫 𝐇𝐞𝐚𝐝𝐬, 𝐢𝐭’𝐬 𝐚𝐥𝐥 𝐡𝐄𝐃𝐒. The doctors have been using the wrong heads, it’s hEDS that’s our problem! Or ...
13/08/2026

𝐈𝐭’𝐬 𝐧𝐨𝐭 𝐚𝐥𝐥 𝐢𝐧 𝐨𝐮𝐫 𝐇𝐞𝐚𝐝𝐬, 𝐢𝐭’𝐬 𝐚𝐥𝐥 𝐡𝐄𝐃𝐒.

The doctors have been using the wrong heads, it’s hEDS that’s our problem! Or cEDS, clEDS, vEDS, HsD etc.

Gives us a thumbs up 👍 if you have been told it’s all psychological (in our head).

Address

Brisbane City, QLD

Alerts

Be the first to know and let us send you an email when Ehlers-Danlos Australia posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Ehlers-Danlos Australia:

Shortcuts

Share